Form 4: Emergent BioSolutions Executive Jennifer Lynne Fox Reports Acquisition of 15,000 Shares

EVP Jennifer Lynne Fox reports acquisition of 15,000 shares of Emergent BioSolutions Inc. through restricted stock units.

Summary

• On July 11, 2024, Jennifer Lynne Fox, EVP, Ext Aff, GC, Corp Sec of Emergent BioSolutions Inc., acquired 15,000 shares of common stock.
• The acquisition was through the grant of restricted stock units (RSUs) under the company's Amended and Restated Stock Incentive Plan.
• The RSUs vest in one installment on the first anniversary of the grant date, assuming continued service with the company.
• Each RSU represents the right to receive one share of Emergent BioSolutions Inc. common stock.
• Following the transaction, Fox directly owns 186,382 shares of Emergent BioSolutions Inc.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It reflects a standard transaction of stock options vesting, which is neither overtly positive nor negative.

Positives

• The acquisition of shares by an executive may signal confidence in the company's future performance.

Future Outlook

The restricted stock units vest in one installment on the first anniversary of the date of grant assuming continued service with the company.

Industry Context

Executive stock ownership is a common practice in publicly traded companies and is often used to align the interests of management with those of shareholders.

Stakeholder Impact

• The acquisition of shares by an executive could positively influence shareholder sentiment.

Key Dates